Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01178 (oxytocin)
 15,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Intraamniotic urea and prostaglandin F2 alpha (PGF2a) combinations for midtrimester abortion were compared in the following series: 8 multiparas given 80 gm urea in 135 ml 5% dextrose and 5 mg PGF2a, 8 multiparas given urea only, 150 nulliparas and multiparas given urea and 5 mg PGF2a, and 180 given urea and 10 mg PGF2a. In the 2 small series, there was 1 failure in the urea group. Mean abortion times were 28.8 hours after urea, 18.3 hours after urea and 5 mg PGF2a, and 16.3 and 17.5 hours in the 2 large series given urea and 10 and 5 mg PGF2a, respectively. Urea caused loss of fetal heart tones within 2 hours, had a half-life in amniotic fluid of 3 hours, caused a low frequency of late emesis, and resulted in short-lived burning or warm sensation in 1 case of accidental intravascular injection. Oxytocin infusions were used frequently for failure to abort within 24 hours, or lack of uterine contractions after membrane rupture or incomplete abortion. PGF2a accelerated uterine tone, frequency, and integrated uterine pressure over the values measured in subjects given urea only.
 ...
PMID:Intra-amniotic urea and prostaglandin F2alpha for midtrimester abortion: clinical and laboratory evaluation. 7 92

100 term (gestation at least 37 weeks), vertex presenting, vaginally delivered, and fetomaternal blood-group-compatible neonates were studied to evaluate the pathogenesis of neonatal hyperbilirubinaemia induced by oxytocin. 50 infants were born after oxytocin infusion for augmentation of labour and the other 50 were delivered spontaneously. The babies born after oxytocin induction of labour attained significantly higher serum bilirubin levels at age 72 +/- 12 hours than the controls. Infants born after oxytocin showed significant hyponatraemia, hypo-osmolality, and enhanced osmotic fragility of erythrocytes at birth. These biochemical and physiological alterations can be explained by the antidiuretic effects of oxytocin and concomitant administration of large quantities of electrolyte-free dextrose solutions used to administer it. Our observations suggest that cord serum sodium and/or osmolality should be estimated and infants with serum sodium less than 125 mmol/l and/or osmolality less than 260 mmol/kg should be considered for prophylactic administration of phenobarbitone.
 ...
PMID:Pathogenesis of oxytocin-induced neonatal hyperbilirubinaemia. 47 17

Four cases of water intoxication in connection with oxytocin administration during saline-induced abortions are described. The mechanism of water intoxication is discussed in regard to these cases. Oxytocin administration during midtrimester-induced abortions is advocated only if it can be carried out under careful observations of an alert nursing staff, aware of the symptoms of water intoxication and instructed to watch the diuresis and report such early signs of the syndrome as asthenia, muscular irritability, or headaches. The oxytocin should be given only in Ringers lactate or, alternately, in Ringers lactate and a 5 per cent dextrose and water solutions. The urinary output should be monitored and the oxytocin administration discontinued and the serum electrolytes checked if the urinary output decreases. The oxytocin should not be administered in excess of 36 hours. If the patient has not aborted by then the oxytocin should be discontinued for 10 to 12 hours in order to perform electrolyte determinations and correct any electrolyte imbalance.
 ...
PMID:Water intoxication associated with oxytocin administration during saline-induced abortion. 80 83

1. In conscious lactating goats a significant correlation was found between blood-milk potential difference (p.d.) and milk [lactose] such that in goats with a lower milk [lactose], milk was more negative with respect to blood.2. When mannose was substituted for glucose in the substrate mixture of isolated perfused goat mammary glands, milk yield and milk [lactose] fell while milk [Na] and [K] increased; in parallel experiments the blood-milk p.d. changed such that milk became more negative with respect to blood. These changes were reversed following the addition of glucose.3. When milk was made hypertonic by the addition of hyperosmotic sucrose or lactose solutions, water entered milk osmotically and milk became electrically less negative or even positive with respect to blood in goats, cows and guinea-pigs.4. No effect on p.d. was apparent following the addition of isosmotic sucrose to milk in goats.5. When milk was held in the teat of goats by a pneumatic cuff around the base of the teat, no effect on p.d. was apparent when hyperosmotic sucrose was introduced into this teat pouch.6. It is suggested that waterflow-induced potentials (the streaming potential and the transport number effect) can be induced across the mammary epithelium.7. In goats exogenous oxytocin lowered milk [lactose] and blood-milk p.d. became less negative with respect to blood.8. In non-lactating and mastitic glands of goats the blood-milk p.d. was within 0.5-2.5 mV of zero.9. The effects of oxytocin, and the low p.d. in non-lactating and mastitic glands, are compatible with the view that in such circumstances there is a paracellular pathway across the mammary epithelium which partially short-circuits the two sides.10. It is suggested that, with water being drawn osmotically into milk to dilute newly formed lactose, waterflow-induced potentials may be responsible for establishing the normal p.d. across the apical membrane of the secretary cell, thereby keeping milk [K] and [Na] lower than in intracellular fluid.
 ...
PMID:Mechanism of milk secretion: milk composition in relation to potential difference across the mammary epithelium. 90 3

Pharmacological doses of insulin (3-25 U/kg sc) elicited feeding and increased gastric motility in rats. In contrast, the glucose analogue 2-deoxy-D-glucose (2-DG), given ip in doses known to increase food intake, had dose-dependent effects on gastric motility: 100 and 200 mg/kg 2-DG increased gastric motility, whereas 500 mg/kg 2-DG virtually eliminated gastric contractions. This latter result resembled the known effects on gastric motility of cholecystokinin (CCK) and LiCl. Moreover, like CCK and LiCl, 500 mg/kg 2-DG stimulated pituitary oxytocin (OT) secretion, and its effects on gastric motility and OT secretion were potentiated by pretreatment with the opioid antagonist naloxone. In contrast, OT secretion was not affected by insulin-induced hypoglycemia with or without naloxone pretreatment. These results suggest that there are two components to the effects of 2-DG on gastric motility: an insulin-like excitatory component and a CCK-LiCl-like inhibitory component. The latter inhibitory component may be mediated by the paraventricular nucleus of the hypothalamus, which has already been implicated in the inhibitory control of gastric motility.
 ...
PMID:Effects of glucoprivation on gastric motility and pituitary oxytocin secretion in rats. 220 80

Oral prostaglandin E2 tablets (group I) and iv Oxytocin (group II) were evaluated in 120 randomly selected women subjected to induction of labour. In group I, 60 women received oral prostaglandin E2 tablets in incremental doses from 0.5-1.5 mg hourly, depending upon the parity and Bishop score of the patient. Group II women received oxytocin iv in 5 per cent dextrose, starting at a rate of 2 mU/min and gradually increasing to a maximum of 64 mU/min. Overall success rate in group I (prostaglandin E2) and group II (intravenous oxytocin) was 85 and 93.3 per cent respectively (P greater than 0.05). In the favourable group (Bishop score 6-13) the induction delivery interval (IDI) for group I and group II was 8.86 h and 7.95 h respectively (P greater than 0.05), while in the unfavourable group (Bishop score less than or equal to 5), the IDI for the respective groups were 13.42 h and 10.11 h (P less than 0.05). Side effects with prostaglandin E2 were mostly mild gastrointestinal ones. A significantly higher incidence of foetal distress was observed with intravenous oxytocin (15%) as compared to prostaglandin E2 (3.33%). Oral prostaglandin E2 was thus found to be a better alternative to intravenous oxytocin in multiparous women with favourable Bishop score (greater than 6) and in those in whom fluid retention is to be avoided (e.g., conditions like toxemias, renal disease).
 ...
PMID:Comparative evaluation of oral prostaglandin E2 & intravenous oxytocin for induction of labour. 262 13

Bovine conceptuses exert an antiluteolytic (anti-PGF-2 alpha) effect on the uterus by decreasing the secretion of PGF that results in maintenance of the CL. Basal and oxytocin-stimulated secretion rates of PGF from perifused endometrium are lower at Day 17 of pregnancy than at Day 17 of the oestrous cycle, probably because of increased amounts of an intracellular, endometrial PG-synthesis inhibitor which is present in the 100,000 g cytosolic supernatant, is proteinaceous, and acts in a noncompetitive manner with respect to arachidonic acid. The antiluteolytic signal in bovine conceptus secretory proteins (bCSP) is bovine trophoblast protein-1 (bTP-1), a group of 7 isomers of N-linked glycoproteins in two size classes (22,000 high-mannose and 24,000 complex types) that are related immunologically to ovine trophoblast protein-1 (oTP-1). Incubation of endometrial explants of Day-17 cyclic cows with bCSP and bTP-1 induced PG-synthesis inhibitor activity and reduced PGF secretion. Intrauterine infusion of bTP-1 from Days 15.5 to 21 extended the interoestrous interval from 19.5 to 26.0 days. Intrauterine infusion of interferon-alpha I 1 through the cervix from Day 15.5 to 21 extended the interoestrous interval from 22.8 to 26.8 days. Platelet-activating factor (PAF) and interferon-alpha I 1 alter PG secretion of endometrial explants (PAF decreases PGF and increases PGE-2; interferon-alpha I 1 does not alter PGF and increases PGE-2 secretion) but neither induces activity of the endometrial PG-synthesis inhibitor. In conclusion, bovine conceptuses exert a paracrine effect through the secretion of bTP-1 to induce an endometrial intracellular inhibitor of PGF synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Antiluteolytic effects of bovine trophoblast protein-1. 281 Feb 37

The effects of intrapartum infusion of dextrose or Hartmann's solution on maternal and cord blood glucose were studied. Patients with and without infusion of intravenous fluids during labor were randomly selected and allocated to one of three groups. Group I received 5% dextrose solution as a vehicle for oxytocin (dextrose group), group II received Hartmann's solution (Hartmann group) and group III did not receive any intravenous infusion (control group). Each group consisted of 16 patients. Routine labor ward procedures were followed. Maternal and cord blood samples were taken at delivery. Maternal blood glucose concentrations were significantly lower in the Hartmann group than in the dextrose and control groups, showing a dilution effect of Hartmann's solution. Cord blood glucose concentrations did not differ significantly between the three groups, indicating that maternal infusion of dextrose or Hartmann's solution in routine intrapartum management would have no adverse effects on fetal blood glucose.
 ...
PMID:Effects of intrapartum intravenous infusion of 5% dextrose or Hartmann's solution on maternal and cord blood glucose. 331 May 4

Maternal and umbilical cord plasma sodium concentrations at delivery following routine labour ward management in uncomplicated pregnancies were studied. Three groups, each consisting of 16 patients, were recruited during labour. One group received 5% dextrose solution for administration of oxytocin. Another group received Hartmann's solution with epidural analgesia. The remaining group received no fluid (controls). There was no difference in the maternal and umbilical cord plasma sodium concentrations between patients who received 5% dextrose solution or Hartmann's solution and controls. Mild hyponatraemia (plasma sodium between 131 and 134 mmol/l) was common in all groups of mothers but severe hyponatraemia (less than 130 mmol/L) was rare. Similarly transplacental hyponatraemia was uncommon. There was no correlation between maternal plasma sodium concentration and the amount of fluid given. It was concluded that intravenous 5% dextrose solution and Hartmann's solution given during labour would not lead to significant hyponatraemia in the mother or fetus if the volume given was less than 0.6 litre.
 ...
PMID:Intrapartum fluid administration and sodium concentration in maternal and umbilical cord plasma. 365 92

To determine the effects of fluid restriction in induced labour with oxytocin in 5% dextrose solution, maternal venous blood and fetal cord venous blood were examined in 164 mothers in induced labour and 29 mothers with a spontaneous onset of labour. After satisfactory uterine activity was induced either the oxytocin infusion was managed according to routine delivery unit practice (n = 36), or infusion rates were halved (n = 45), or quartered (n = 43), or discontinued (n = 40). Despite fluid restriction during labour the mean sodium concentration in maternal blood or cord blood had fallen to a similar extent in all four induced groups at delivery. Potassium, urea, creatinine, total protein, and albumin in maternal blood or cord blood were affected differently by induced labour as compared with sodium. The fall in sodium concentration in maternal blood was a more consistent reflection of the total volume of fluid received, mean infusion rates and cord blood sodium after infusion rates were quartered or discontinued. The incidence of hyponatraemia was 5% in mothers and 8% in infants. A comparison of hyponatraemic and normonatraemic cord blood showed no significant differences in serum bilirubin levels or red cell counts, but more hyponatraemic infants developed neonatal jaundice. It is suggested that in induced labour fluid restriction alone does not prevent hyponatraemia and neonatal jaundice.
 ...
PMID:Oxytocin induction of labour: hyponatraemia and neonatal jaundice. 377 Feb 80


1 2 3 4 Next >>